Stocks
Zymeworks Inc.ZYME
NASDAQHealthcareBiotechnology$26.24
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing antibody-drug conjugates and bispecific antibodies for cancer treatment. Its lead candidate, ZW49, targets HER2-positive solid tumors, and the company has partnerships with major pharmaceutical firms. Investors track Zymeworks for its oncology pipeline and potential in the precision medicine space.
52W Range: $18.20-$31.97
Congressional Interest in Zymeworks Inc. (ZYME)
1 member of Congress has disclosed 1 trade in Zymeworks Inc. (ZYME), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading ZYME?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2010-12-10 | NAN A. S. HAYWORTH | sell | $50K-$100K |